CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer
PHASE2CompletedINTERVENTIONAL
Enrollment
50
Participants
Timeline
Start Date
February 29, 2004
Primary Completion Date
June 30, 2007
Conditions
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
Interventions
DRUG
temsirolimus
Given IV
OTHER
laboratory biomarker analysis
Correlative studies
Trial Locations (1)
55905
North Central Cancer Treatment Group, Rochester
All Listed Sponsors
lead
National Cancer Institute (NCI)
NIH
NCT00079235 - CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter